Diabetes in France continues to increase

Diabetes in France continues to increase

2024-11-13 22:00:00

Each year, diabetes continues to progress and affects several million people, particularly young people under 20 with type 1 diabetes. The surveillance program developed by Public Health France aims to provide indicators of frequency, severity and of development of diabetes in France. On the occasion of World Diabetes Day, Public Health France is publishing updated diabetes surveillance data in 2023, also available on its Géodes platform (prevalence, complications, frequency of monitoring of recommended examinations).

Increase in type 1 diabetes among those under 20 in France

The number of people living with type 1 diabetes under the age of 20 is increasing every year. In 2023, more than 31,000 young people will be affected by this disease. This number increases every year: it was 20,300 young people in 2012 and reached 31,400 in 2023. It is essential to diagnose it as quickly as possible to avoid serious complications which can lead to coma.
Type 1 diabetes is an autoimmune disease that generally appears in childhood or adolescence and is detected following warning symptoms. This disease is linked to many factors, both genetic and environmental. One of the challenges of research on type 1 diabetes is to identify these different risks.

Number of young people under 20 living with type 1 diabetes

Learn more

Access the latest data on the number of cases and prevalence of type 1 diabetes in young people are available at Géodes.

Diabetes: a disease still on the rise

In 2023, diabetes (all types combined) continued to increase. The disease is more common in men than in women, with the exception of overseas territories where women are most affected.

In France in 2023, more than 3.8 million people were being treated with medication for diabetes, or 5.6% of the population.
Territorial disparities remain very marked with a much higher frequency of diabetes in the overseas departments and regions and in Seine Saint Denis. In contrast, the departments located in the west of France and particularly in Brittany record the lowest frequencies.

Chronic complications linked to diabetes which remain common

In 2023, hospitalizations for chronic complications linked to diabetes will remain very frequent. Among people aged 45 and over, treated with medication for diabetes, podiatric complications (foot wounds and lower limb amputations) affect 981 and 286/100,000 people respectively. As for cardio and neurovascular complications (stroke and myocardial infarction with ST segment elevation) affect 589 and 223/100,000 people respectively.

Learn more

Access the standardized incidence rates of complications linked to diabetes on Géodes:

Also, clinical monitoring of people with diabetes is guided by care pathway recommendations established by the High Health Authority. Since 2020, the frequency of monitoring recommended examinations has remained fairly stable.

Public Health France takes action against diabetes and cardiovascular diseases in Europe

Public Health France is committed to the joint European action Joint Action on CARdiovascular diseases and DIabetes (JACARDI) which aims to reduce the burden of cardiovascular diseases and diabetes in the member states of the European Union.

This coordinated approach, on a European scale, makes it possible to obtain a greater impact than isolated national actions, thus contributing more effectively to the development of ambitious and sustainable public health actions.

Public Health France leads and participates in several projects in this joint action. They concern the early detection of type 2 diabetes, the prevention of complications or the improvement of diabetes epidemiological surveillance systems.

Public Health France supports a campaign on the importance of early diagnosis among young people

The association Aide aux Jeunes Diabétiques (AJD) is launching a national campaign this year “Together, let’s spot the signs of type 1 diabetes before it is too late”. It aims to promote early diagnosis and help limit complications ranging from moderate ketoacidosis to coma*.

The AJD Ketoacidosis Prevention Observatory shows that in 2023, more than 4 out of 10 children or adolescents under the age of 15 were diagnosed much too late, with moderate ketoacidosis (24.9%) or severe (17.5%), or even a diabetic coma (3%). It is therefore essential to promote early diagnosis, particularly through better knowledge of symptoms by parents and health professionals.
For more information on the campaign, visit the AJD website.

*The messages in these documents, designed by the AJD, in complete independence from private funders, are supported and validated by Public Health France.

1732682447
#Diabetes #France #continues #increase

Leave a Replay